Lima Corporate was awarded three new Orthopaedic Data Evaluation Panel ratings for hip implants in the U.K. The ratings are intended to indicate that a device’s clinical performance falls in line with National Institute for Health and Care Excellence guidelines for implant survivorship.
AxioMed modified terms of a previously-signed 15-year exclusive license agreement with DSM Biomedical, holder of the patent on polymer technology used in AxioMed’s viscoelastic disc replacement.Â
Carevature commenced limited U.S. launch of Dreal™ products for spinal decompression. Full launch is slated for 2017. The system is also available for sale in the EU.
CartiHeal received FDA approval of its Investigational Device Exemption application submitted for the Agili-C™ implant, in support of a Premarket Approval application.
Stryker Orthopaedics reached an agreement to compensate additional eligible U.S. patients who underwent surgery to revise a Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem prior to 12/19/16.Â
Implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry confirm positive early results for DePuy Synthes’ ATTUNE® Knee.Â
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more